Sally Watkins
Acute Care · Columbus, GANPI 1437634011
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,719 of the $7,689 with a category attached, or 87.4%. It is spread thinly across 27 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 353 payments — averaging $21.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Novartis$802
- Abbott$738
- Pfizer$567
- Bayer$448
- E.r. Squibb & Sons, L.L.C.$422
- plus $3K from 21 others
What the payments were for
- Travel & lodging$97013%
- Food & beverage$6,71987%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 16 | $1,825 |
| Novartis | 51 | $802 |
| Abbott | 19 | $738 |
| Pfizer | 46 | $567 |
| Bayer | 29 | $448 |
| E.r. Squibb & Sons, L.L.C. | 33 | $422 |
| Novo Nordisk | 21 | $358 |
| Johnson & Johnson | 30 | $339 |
| Esperion Therapeutics, Inc. | 13 | $305 |
| Amgen | 15 | $282 |
| AstraZeneca | 21 | $277 |
| United Therapeutics Corporation | 8 | $240 |
| Shockwave Medical, Inc | 1 | $213 |
| Daiichi Sankyo Inc. | 8 | $177 |
| Boehringer Ingelheim | 9 | $158 |
| Actelion Pharmaceuticals US, Inc. | 8 | $137 |
| Sanofi-aventis U.S. LLC | 6 | $98 |
| Alnylam Pharmaceuticals Inc. | 4 | $69 |
| Merck | 3 | $61 |
| Lexicon Pharmaceuticals, Inc. | 3 | $53 |
| Lantheus Medical Imaging, Inc. | 2 | $33 |
| Scpharmaceuticals Inc. | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Cvrx, Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $13 |
| Vivaquant Inc, Dba Rhythm Express | 2 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,689 in reported general payments places this provider in the 95th percentile of 679 acute care providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 16 | $17,227 |
| Metoprolol Succinate | 16 | $312 |
| Furosemide | 12 | $55 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $277 | $17,22716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 679 acute care providers in Georgia.
Other acute care in Columbus
- Erin CulleferColumbus$7K
- Rachel WarburtonColumbus$4K
- Stephanie RobertsonColumbus$3K
- Darryl TurnerRinggold$21K
- Bryce CowgillCumming$16K
- Stacy CreelSavannah$15K
- Susan BeitzellAthens$13K
- Crystal KuhnCumming$12K
- Mark ClarkGainesville$10K
- Sarah WymanAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.